drug · small molecule
patient view →pirenzepine
Phase 2updated 2mo agoby WinSanTor Inc🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for gastroesophageal reflux disease and peptic ulcer and 3 investigational indications.
targets
Muscarinic acetylcholine receptor M1
all catalysts(1)
phase 2 completion · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that